Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model

British Journal of Cancer

Volumn 75, Issue 2, 1997, Pages 190-195

  Hyytinen, E R ^a   Thalmann, G N ^b,c   Zhau, H E ^c,d   Karhu, R ^a   Kallioniemi, O P ^a   Chung, L W K ^c,d   Visakorpi, T ^a,e  

^a UNIVERSITY OF TAMPERE   (Finland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Comparative genomic hybridization; Genetic aberration; LNCaP cell line; Metastases; Prostatic carcinoma

Indexed keywords

ANDROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CANCER MODEL; CARCINOGENICITY; CHROMOSOME 13Q; CHROMOSOME 20P; CHROMOSOME 21Q; CHROMOSOME 4; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; DNA HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; HORMONAL REGULATION; HUMAN; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031026519     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.32     Document Type: Article

References (26)

1. Blackard CE, Byar DP and Jordan WP Jr for the Veterans Administration Cooperative Urological Research Group (1973) Orchidectomy for advanced carcinoma: a re-evaluation. Urology 1: 533-560
2. Brewster SF, Browne S and Brown KW (1994) Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151: 1073-1077
3. Cher KL, MacGrogan D, Bookstein R, Brown JA, Jenkins RB and Jensen RH (1994) Comparative genomic hybridization, allelic imbalance and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chrom Cancer 11: 153-162
4. Devilee P, van Vlient M, van Sloun P, Dijkshoorn K, Hermans J, Pearson PL and Cornellisse CJ (1991) Allelotype of human breast carcinoma: a second major site of loss of heterozygosity is on chromosome 6q. Oncogene 6: 1705-1711
5. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
6. Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ and Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67: 551-559
7. Gibas Z, Becher R, Kawinski E, Horoszewicz J and Sandberg A (1984) A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet Cytogenet 11: 399-104
8. Gittes RF (1991) Carcinoma of the prostate. N Engl J Med 324: 236-245
9. Gleave ME, Hsieh J-T, Gao C, von Eschenbach AC and Chung LWK (1991) Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51: 3753-3761
10. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818
11. Joos S, Bergerheim U, Pan Y, Matsuyama H, Bentz M, du Manoir S and Lichter P (1995) Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chrom Cancer 14: 267-276
12. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invent Urol 17: 16-23
13. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
14. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chrom Cancer 10: 231-243
15. Koivisto P, Hyytinen E, Palmberg C, Tammela T, Visakorpi T, Isola J and Kallioniemi O-P (1995) Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. Am J Pathol 147: 1608-1614
16. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P and Collins VP (1991) Allelotyping of human prostatic adenocarcinoma. Genomics 11: 530-536
17. Lundgren R, Heim S, Mandahl N, Anderson H and Mitelman F (1992) Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J Urol 147: 784-788
18. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51: 5449-5453
19. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi O-P, Waldman FM, Gray JW and Pinkel D (1995) Computer image analysis of comparative genomic hybridization. Cytometry 19: 10-26
20. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281
21. Tanner M, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Owbel D, Shadravan F, Hintz, M, Kuo W-L, Waldman F, Gray J and Kallioniemi O-P (1994) Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 54: 4257-4260
22. Thalmann GN, Anezinis PE, Chang, S-M, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC and Chung LWK (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-2581
23. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ and Kallioniemi O-P (1995a) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55: 342-347
24. Visakorpi T, Hyytinen E, Koivisto P, Tanner, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J and Kallioniemi O-P (1995b) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401-406
25. Wingo PA, Tong T and Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45: 8-30
26. Wu H-C, Hsieh J-T, Gleave ME, Brown NM, Pathak S and Chung LWK (1994) Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57: 406-412